Dyslipidemia in a cohort of HIV-infected latin american children receiving highly active antiretroviral therapy

Journal of Tropical Pediatrics

Volumn 57, Issue 5, 2011, Pages 324-332

  Brewinski, Margaret ^a,b   Megazzini, Karen ^c   Freimanis Hance, Laura ^c   Cruz, Miguel Cashat ^d   Pavia Ruz, Noris ^d   Della Negra, Marinella ^e   Ferreira, Flavia Gomes Faleiro ^f   Marques, Heloisa ^g   Hazra, Rohan ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^c WESTAT   (United States)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^e INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cholesterol; HIV; Pediatric; Triglycerides

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD HEALTH; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SOUTH AND CENTRAL AMERICA;

EID: 84155161621     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq089     Document Type: Article

References (26)

1. Carter RJ, Wiener J, Abrams EJ, et al. Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis. J Acquir Immune Defic Syndr 2006;41:453-60.
2. Cheseaux JJ, Jotterand V, Aebi C, et al. Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases. J Acquir Immune Defic Syndr 2002;30:288-93.
3. Farley J, Gona P, Crain M, et al. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr 2005;38:480-7.
4. Gafni RI, Hazra R, Reynolds JC, et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. Pediatrics 2006;118:e711-18.
5. Lainka E, Oezbek S, Falck M, et al. Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy. Pediatrics 2002;110:e56.
6. McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS 2004;18:1753-68.
7. Tassiopoulos K, Williams PL, Seage GR 3rd, et al. Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children. J Acquir Immune Defic Syndr 2008;47:607-14.
8. Taylor P, Worrell C, Steinberg SM, et al. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics 2004;114:e235-42.
9. Chantry CJ, Hughes MD, Alvero C, et al. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy. Pediatrics 2008; 122:e129-38.
10. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 2004;18:1443-51.
11. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report. Geneva, Switzerland: WHO, UNAIDS, UNICEF, 2009.
12. Children and AIDS: A Stocktaking Report. New York, NY: Unite for Children, Unite Against AIDS, 2007.
13. Antiretroviral Therapy for HIV Infection in Infants and Children WHO 2010. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf (28 September 2010, date last accessed).
14. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008;359:2233-44.
15. Hazra R, Stoszek SK, Hance LF, et al. Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol 2009;38:1207-14.
16. A SAS Program for the CDC Growth Charts. http://www.cdc.gov/nccdphp/dnpa/growthcharts/resources/sas.htm. (4 December 2008, date last accessed).
17. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
18. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics 2008;122:198-208.
19. Miller TL, Orav EJ, Lipshultz SE, et al. Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. J Pediatr 2008; 153:491-7.
20. Weiss R, Caprio S. The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 2005;19:405-19.
21. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
22. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6.
23. McGill HC Jr, McMahan CA, Malcom GT, et al. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological determinants of atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1997;17:95-106.
24. Raitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003;290:2277-83.
25. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. 23 February 2009 http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf (2 July 2010, date last accessed).
26. Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006;114:2710-38.